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Abstract: Iridium-catalyzed asymmetric hydrogenation has emerged as a highly efficient method for the
synthesis of enantiomerically pure compounds. This account summarizes our recent efforts in this field. We
have developed a new type of P,O-ligand that was successfully applied to the asymmetric hydrogenation of α,β-
unsaturated carbonyl compounds. Furthermore we have demonstrated the potential of known iridium catalysts
in the hydrogenation of α,β-unsaturated boronic esters. And finally we could demonstrate the utility of iridium-
catalyzed asymmetric hydrogenation in the formal synthesis of the natural product Platensimycin.
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Introduction
Asymmetric hydrogenation is a pow-
erful tool to convert prochiral substrates
into chiral products with high enantio-
meric purity. The reaction fulfills all the
requirements for modern asymmetric
synthesis, such as perfect atom economy,
mild conditions, low catalyst loading and
high conversion.
[1]
The importance of this
transformation has been recognized by
awarding the pioneering work of Knowles
and Noyori with the Nobel Prize in 2001.
[2]
While Knowles used chiral rhodium
complexes for the hydrogenation of α,β-
dehydroamino acids, which finally resulted
in the well-known l-Dopa process imple-
mented at Monsato,
[2a]
Noyori introduced
ruthenium-BINOL complexes as catalysts
for the reduction of functionalized C=C
and C=O bonds.
[2b]
Despite the vast variety
of chiral Rh and Ru catalysts developed so
far (many of them are commercially avail-
able), the range of substrates that can be
hydrogenated with high enantioselectivity
is limited. In general, both rhodium und
ruthenium complexes require substrates
bearing a coordinating functional group
next to the C=C bond in order to achieve
high levels of ee.
[3]
While Rh and Ru cata-
lysts show only low reactivity toward un-
functionalized tri- or tetrasubstituted C=C
bonds, Crabtree’s group showed already in
the 1970s that cationic iridium complexes
bearing a pyridine and phosphine ligand
can promote the hydrogenation of tri- or
tetraalkyl-substituted olefins with high
efficiency.
[4]
In search of a chiral version of
Crabtree’s catalyst, phosphineoxazoline
(PHOX) ligands were evaluated in the irid-
ium-catalyzed asymmetric hydrogenation
of imines and olefins.
[5]
However, catalyst
deactivation during the reaction led to in-
complete conversions, therefore relatively
high catalyst loadings (>4 mol%) were re-
quired. After extensive experimental stud-
ies, a relatively simple solution to avoid
catalyst deactivation was found, by chang-
ing the counter ion.
[6]
By using a bulky,
apolar, weakly coordinating anion like
tetrakis[3,5-bis(trifluoromethyl)phenyl]
borate (BAr
F
−
),
[7]
full conversions could
be achieved even at low catalyst loadings
(>0.02 mol%). Iridium complexes contain-
ing BAr
F
−
as counter ion proved to be less
sensitive to moisture and oxygen than the
corresponding hexafluorophosphates and
moreover, purification by column chroma-
tography was possible.
[8]
Having solved the deactivation prob-
lem, the development of new P,N-ligand
families was investigated aiming to broad-
en the substrate scope. In our group several
heterocyclic ligand systems (oxazolines,
imidazolines and pyridines) containing a
phosphine or a phosphinite unit were de-
veloped and used for iridium-catalyzed
asymmetric hydrogenation. The classes
of ligands providing excellent results for
the hydrogenation of terminal, tri- and
even tetrasubstituted olefins are shown in
Fig. 1.
[9]
During the last ten years many further
ligands for this particular transformation
have been introduced by other research
groups as well.
[10]
Most noteworthy are
thiazole-, aminophosphine- and pyrano-
side P,N-based systems, developed by
Andersson and coworkers.
[11]
Besides P,N-
ligands, C,N-ligands having a coordinat-
ing N-heterocyclic carbene unit also gave
promising results.
[12]
All these new ligands
enhanced the substrate scope to various
types of C=C bonds, allowing asymmet-
ric hydrogenations of vinyl fluorides,
[13]
vinyl ethers,
[14]
enol phosphinates,
[15]
vi-
nyl diphenylphosphine oxides,
[16]
vinyl
boronates,
[17]
chromenes,
[18]
furanes,
[19]
indoles,
[20]
enamines,
[21]
protected and un-
protected allylic alcohols,
[22]
and unsatu-
rated carbonyl compounds.
[22b,22c,23]
Development of New Catalysts
Representative P,N-ligands for the irid-
ium-catalyzed asymmetric hydrogenation
of various olefins are depicted in Fig. 1.
All these bidentate ligands were designed
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drance around the carbonyl functionality
of amido- or ureaphosphines (12 and 14),
gave the highest enantioselectivities (Table
1, entries 4 and 8) for 21. For substrate 20
the best enantiomeric excess of 91% was
achieved with the tetrasubstituted urea 18
(Table 1, entry 13).
The β-methyl-substituted α,β-unsat-
urated carboxylic ester (24) was reduced
with generally higher enantioselectivities
(Fig. 3). Amidophosphine 11 as well as
the urea-phosphines 16 and 18 achieved
enantioselectivities ≥98%.All of these cat-
alysts bear a sterically demanding substitu-
ent at the carbonyl functionality in com-
bination with a stronger electron donating
dialkyl phosphine. The reduction of α,β-
unsaturated carboxylic esters 25 and 26
proceeded with complete conversion but
lower enantioselectivities. Remarkably the
α-substituted ester 26was reduced with up
to 91% ee, whereas its β-methyl substitut-
ed analog 25 was only reduced with up to
77% ee (Fig. 3). Surprisingly, in this case
the diphenylphosphine substituted ligand
14 allowed the highest selectivity.
[24]
The α,β-unsaturated ketones 27 and
28 were previously reduced by iridium
catalysts with sulfoximine-derived P,N-
ligands with enantioselectivities of up to
81% ee.
[23c]
Our P,O-ligands showed enan-
to bind to the metal through a heterocyclic
sp
2
-nitrogen donor in combination with
a trisubstituted phosphorus atom. In the
course of our ongoing efforts to identify
other active and selective catalysts, we dis-
covered new proline-based iridium com-
plexes. These complexes are formed by
bidentate chelation of P,O-proline-based
ligands to the metal center with a phos-
phorus atom, and a carbonyl oxygen atom
(Fig. 2).
Thanks to their modular synthesis these
P,O-ligands are readily accessible in few
steps and in good yields starting from pro-
line. This allows the preparation of cata-
lysts whose steric and electronic charac-
teristics can be tuned with ease. In order
to evaluate the results depending on the
structural motif of both catalyst and sub-
strates, we carried out a broad screening
using functionalized and unfunctionalized
olefins.
[24]
These catalysts proved to be
particularly well-suited for the reduction
of C=C bond of α,β-unsaturated ketones
and carboxylic esters.
Pyridyl phosphinite basedP,N-catalysts
(9) have previously been reported to re-
duce α-methyl substituted α,β-unsaturated
esters (20 and 21) with excellent enantio-
meric excess (ee) up to 97% and respec-
tively 99%.
[25]
The proline-based P,O-
ligands allow for ees up to 95% for this
type of substrate (Table 1, entries 4 and 8).
Conversion was complete after 2 h with al-
most all P,O-ligands. Increased steric hin-
Table 1. Iridium-catalyzed asymmetric hydrogenation of α-substituted,
α,β-unsaturated esters
a
20, R
3
= Et
21, R
3
= iPr
*
22, R
3
= Et
23, R
3
= iPr
[Ir(cod)
2
]BAr
F
(1 mol%)
then L
*
(1 mol%)
H
2
(50 bar), CH
2
Cl
2
, rt, 2 h
OR
3
O
OR
3
O
Entry R
3
Ligand Yield [%]
b
ee [%]
c
1 Et 11 > 99 90 (R)
2 iPr 11 > 99 89 (R)
3 Et 12 > 99 87 (R)
4 iPr 12 > 99 95 (R)
5 Et 13 > 99 90 (R)
6 iPr 13 > 99 92 (R)
7 Et 14 > 99 86 (R)
8 iPr 14 > 99 95 (R)
9 Et 15 > 79 84 (R)
10 iPr 15 > 87 87 (R)
11 Et 17 > 99 81 (R)
12 iPr 17 > 99 88 (R)
13 Et 18 > 99 91 (R)
14 iPr 18 > 96 94 (R)
15 Et 19 > 99 83 (R)
16 iPr 19 > 99 87 (R)
a
Reaction conditions: [Ir(cod)
2
]BAr
F
(1 mol%), ligand (1 mol%), CH
2
Cl
2
(0.5 m), substrate (250 μmol).
b
Yields were determined by GC analysis
of the reaction mixture after removal of the catalyst.
c
Enantioselectivities
were determined by HPLC analysis using a chiral stationary phase.
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Fig. 1. Iridium catalysts for enantioselective hydrogenation developed in the Pfaltz group.
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Fig. 2. Proline-based P,O-ligands.
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quired.
[28]
On the other hand, iridium cata-
lysts were reported to be more active, since
only 0.5 mol% of catalyst is generally suf-
ficient to reach full conversions.
[17]
In this
case though, high enantioselectivities were
only achieved with certain substrates.
Overall, the scope of rhodium- and
iridium-catalyzed hydrogenation of α,β-
unsaturated boronic esters is still limited,
and this prompted us to screen our cata-
lysts (see Fig. 1) in the hydrogenation of
31.
[29]
To our delight, catalyst 9a gave
already under screening conditions full
conversion and 95% enantiomeric excess
(Table 3). Moreover, a series of differ-
ent bisboronic esters having various sub-
stituents at the C=C bond (31–34) was
hydrogenated with good to excellent ees.
Bisboronic esters (31–34) also gave ac-
cess to alkenyl-monoboronic esters, given
the higher reactivity of the terminal boron
group allowing chemoselective Suzuki-
Miyaura couplings. Therefore, several
alkenyl boronates were prepared (35–42)
in which the terminal boron was replaced
by various residues. Subjecting substrates
35–40 to the iridium-catalyzed hydroge-
nation excellent selectivities ranging from
95% to 99% ee were achieved. Moreover,
tioselectivities of up to 96% ee for these
substrates, with again complete conversion
after shorter reaction times. Even though
the conversions obtained were good to ex-
cellent, the reduction of the C=C double
bond was sometimes accompanied by the
undesired reduction of the carbonyl bond
of the substrate 27. Nevertheless, this over
reduction could be suppressed by using the
precatalyst in its isolated form instead of
forming the catalyst in situ (Table 2, entries
1, 3, 7, 13 and 15). For the α,β-unsaturated
ketones 27 and 28, again P,O-ligands,
amido- and ureaphosphines, bearing dia-
kylphosphines in combination with a steri-
cally demanding carbonyl moiety proved
to be the most efficient (entries 1-4).
Hydrogenation of α,β-Unsaturated
Boronic Esters
Chiral boronates are highly versatile
compounds,
[26]
since the C−B bond can
be converted into C−O, C−N or even C−C
bonds in a stereospecificmanner.
[27]
Oneat-
tractive method to access these compounds
in a catalytic and enantioselective fashion
is by hydrogenation of alkenylboronic es-
ters. Indeed, experiments using rhodium
catalysts derived from ferrocenyl ligands
led to chiral secondary boronates, which
are not accessible in high enantiomeric
purity via hydroboration. However, rela-
tively high catalyst loading (up to 5 mol%
catalyst) and long reaction times were re-
Table 2. Iridium-catalyzed asymmetric hydrogenation of β-substituted,
α,β-unsaturated ketones
a
27, R
3
= Me
28, R
3
= Ph
*
29, R
3
= Me
30, R
3
= Ph
[Ir(cod)
2
]BAr
F
(1 mol%)
then L
*
(1 mol%)
H
2
(50 bar), CH
2
Cl
2
, rt, 2 h
R
3
O
R
3
O
Entry R
3
Ligand Yield [%]
b
ee [%]
c
1 Me 11 98 (98
e
) 96 (R) (94 (R)
e
)
2 Ph 11 99 94 (R)
3 Me 12 95 (98
e
) 96 (R) (89 (R)
e
)
4 Ph 12 98 95 (R)
5 Me 13 87 86 (R)
6 Ph 13 98 82 (R)
7 Me 14 98 (99
e
) 93 (R) (91 (R)
e
)
8 Ph 14 > 99 95 (R)
9 Me 15 86
d
79 (R)
d
10 Ph 15 86 80 (R)
11 Me 16 95 82 (R)
12 Ph 16 98 90 (R)
13 Me 18 68
d
(94
e
) 92 (R)
d
(94 (R)
e
)
14 Ph 18 94 84 (R)
15 Me 19 88 (94
e
) 87 (R) (87 (R)
e
)
16 Ph 19 96 82 (R)
a
Reaction conditions: [Ir(cod)
2
]BAr
F
(1 mol%), ligand (1 mol%),
CH
2
Cl
2
(0.5 M), substrate (250 μmol).
b
Yields were determined by GC
analysis of the reaction mixture after removal of the catalyst.
c
Enantiose-
lectivities were determined by HPLC analysis using a chiral stationary
phase.
d
Average result of 3 experiments.
e
Results obtained with isolated
precatalyst [(L*)Ir(cod)]BAr
F
(1 mol%).
Table 3. Iridium-catalyzed asymmetric hydrogenation of α,β-unsaturated
boronic esters
abc
9a (1 mol%)
H
2
(50 bar),
CH
2
Cl
2
, rt, 12-15 h
N
O
(t-Bu)
2
P
Ir
BAr
F
Ph
R
B
OO
R'
∗
R
B
OO
R'
9a
B
B
OO
O
O
B
B
OO
O
O
34
>99% conv.
98% ee
31
>99% conv.
[b]
95% ee
[c]
B
B
OO
O
O
B
B
OO
O
O
33
97% conv.
85% ee
32
>99% conv.
72% ee
B
OO
B
OO
OMe
36
>99% conv.
95% ee
38
>99% conv.
97% ee
B
OO
35
98% conv.
>99% ee
B
OO
CF
3
37
>99% conv.
98% ee
B
OO
B
OO
B
O
O
B
OO
39
>99% conv.
99% ee
42
99% conv.
90% ee
41
>99% conv.
97% ee
40
>99% conv.
96% ee
F
a
Reaction conditions: Ir-9a (1 mol%), CH
2
Cl
2
(0.2 M), substrate (50–
100 μmol), 50 bar H
2
, 12–15 hours.
b
Conversion determined by
GC analysis of the reaction mixture after removal of the catalyst.
c
Enantioselectivity determined by GC or HPLC analysis on chiral
stationary phase.
O
O
Ph
O
O
Ph
Ph
O
O
24
(S)-11: > 99% y, 98% ee (R)
(S)-16: > 99% y, 98% ee (R)
(S)-17: > 99% y, 97% ee (R)
(S)-18: > 99% y, 99% ee (R)
(S)-19: > 99% y, 97% ee (R)
26
(S)-13: > 99% y, 87% ee (-)
(S)-14: > 99% y, 89% ee (-)
(S)-15: > 99% y, 86% ee (-)
(S)-18: > 99% y, 91% ee (-)
(S)-19: > 99% y, 86% ee (-)
25
(S)-13: > 99% y, 70% ee (S)
(S)-14: > 99% y, 77% ee (S)
(S)-15: > 99% y, 68% ee (S)
(S)-16: > 99% y, 68% ee (S)
(S)-18: > 99% y, 76% ee (S)
Fig. 3. Selected hydrogenation results of various α,β-unsaturated esters.
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the electronic and steric properties of the
residues introduced had no significant ef-
fect on the stereoselectivity of the reaction.
Substrates 40 and 41 demonstrate that aryl
groups at C=C bond are not essential in or-
der to achieve high ee values. Substrate 42,
bearing the boronic ester group at the less
substituted olefinic carbon, reacted with
lower, but still very good enantioselectiv-
ity (90% ee).
Furthermore, we sought to examine the
relative reactivity of these new substrates
compared to unfunctionalized olefins. As
model substrates for this study we selected
E-α-methylstilbene, bisboronic ester deri-
vate 34 and a mono boronic ester derivate
35. This study showed surprising results.
While E-α-methylstilbene was expected
to be reduced very rapidly, substrate 34
reacted even faster. Using 1 mol% of cata-
lyst full conversion was achieved already
within 5 min. This is remarkably fast, con-
sidering that E-methylstilbene requires
under the same conditions 1 h to be fully
reduced. Therefore, we were able to re-
duce the catalyst loading for substrate 34
to 0.1% still achieving full conversion. On
the other hand, substrate 35 displayed re-
duced reactivity, as it reacted considerably
slower than 34 and E-α-methylstilbene, as
shown in Fig. 4. These observations indi-
cate that besides the steric properties of
the substrates, electronic effects also play
a crucial role.
Applications in the Synthesis of
Complex Molecules
The power of iridium-catalyzed asym-
metric hydrogenation has been demonstrat-
ed in theenantioselectivesynthesisofsever-
al biologically important natural products,
such as (+)- and (−)-Mutisianthol,
[30]
(R)-
(+)-7-demethyl-2-methoxycalamenene,
[31]
MacrocidinA,
[32]
(−)-Spongidepsin,
[33]
and
(+)-Torrubiellone C.
[34]
Herein we would
like to highlight our contribution to the for-
mal synthesis of Platensimycin (Fig. 5) in
collaboration with the Mulzer group. This
natural product recently received much at-
tention because of its unique structural fea-
tures and its potent activity as a new type
of antibiotic.
[35]
After Nicolaou reported the first to-
tal synthesis of racemic Platensimycin in
2006,
[36]
several research groups have been
involved in an asymmetric approach to
it.
[37]
Among them the Mulzer group has
recently reported an elegant approach,
[38]
which involves two hydrogenation reac-
tions as key synthetic transformations.
The first hydrogenation step is an asym-
metric hydrogenation of the unsaturated
ester 44 (Scheme 1). After an extensive
screening of our iridium catalysts (Fig. 1)
we were delighted to observe that complex
10 afforded the desired compoundwith full
conversion and 99% ee. Notably, the cata-
lyst loading could be reduced to 0.2 mol%,
so the hydrogenation could be easier per-
formed on a multigram scale.
The second hydrogenation step in-
volves the diastereoselective reduction of
the tetracyclic dienone 46 (Scheme 2).
Since all experiments to obtain the key
intermediate 49 directly through selective
mono-hydrogenation of 46 failed, a selec-
tive preparation of 48 was attempted. The
twofold 1,4-reduction of 46 proved chal-
lenging due to the poor diastereoselectiv-
ity of the reaction in favor of the desired
ketone 48.
In order to address this issue, we tested
our chiral iridium complexes for this par-
ticular hydrogenation. A thorough screen-
ing of catalysts and reaction conditions
revealed again 10 as an effective catalyst
in terms of both, conversion and diastereo-
selectivity. Using this catalyst the diaste-
reomeric ketones were obtained in 84%
isolated yield and 40:1 ratio in favor of
the desired ketone 48,
[38c]
providing an ef-
ficient route to 49, a key intermediate for
the preparation of Platensimycin.
[36]
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Fig. 4. Conversion over time for the hydrogenation of α,β-unsaturated boronic esters 34, 35 and
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Conclusion
The introduction of chiral P,N-, C,N-,
and recently P,O-iridium complexes has
significantly broadened the application
range of asymmetric hydrogenation. The
aim of this account was to demonstrate
the potential of these catalysts for the hy-
drogenation of new substrate classes and
the opportunities offered for the synthesis
of complex chiral molecules. Although a
wide range of chiral ligands for iridium-
catalyzed hydrogenation is already avail-
able, the search for new ligands providing
different reactivity and selectivity may
still be rewarding, as demonstrated by
our recently developed proline-based P,O-
ligands.
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